Learn more

STICHTING KATHOLIEKE UNIV

Overview
  • Total Patents
    408
  • GoodIP Patent Rank
    8,769
  • Filing trend
    ⇩ 20.0%
About

STICHTING KATHOLIEKE UNIV has a total of 408 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 1983. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are NAT CANCER CT, UNIV HEALTH NETWORK and INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM).

Patent filings per year

Chart showing STICHTING KATHOLIEKE UNIVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Figdor Carl Gustav 30
#2 Rowan Alan Edward 22
#3 Collin Robert Wilhelmus Johanna 20
#4 Cremers Franciscus Peter Maria 20
#5 Netea Mihai Gheorghe 19
#6 Joosten Leonardus Antonius Bernardus 16
#7 Hermans Peter Wilhelmus Maria 16
#8 Schalken Jack A 15
#9 Van Der Meer Johannes Willem Maarten 15
#10 Oosterwijk Egbert 14

Latest patents

Publication Filing date Title
WO2021023863A1 Antisense oligonucleotides rescue aberrant splicing of abca4
WO2020239696A1 Improved administration of glycylcyclines by inhalation
WO2020148400A1 Antisense oligonucleotides for use in the treatment of crpc
WO2020115106A1 Antisense oligonucleotides rescue aberrant splicing of abca4
WO2020130804A1 National individual floating transport infrastructure
EP3815622A1 Flexible endoscopic tissue biopsy device
WO2020043834A1 Polyurethane sheet
WO2020015959A1 Antisense oligonucleotides rescue aberrant splicing of abca4.
US2020407718A1 Antisense oligonucleotides rescue aberrant splicing of ABCA4
NL2023355B1 Oropharyngeal airway device
NL2022660B1 Heart Assist Device
GB201902702D0 Method of producing a bioactive surface
WO2019166549A1 Minigene for the treatment of usher syndrome type 2a and ush2a-associated retinitis pigmentosa
WO2019145562A1 New potent sialyltransferase inhibitors
WO2020043321A1 Synergistic combinations of amino acid depletion agent sensitizers (aadas) and amino acid depletion agents (aada), and therapeutic methods of use thereof
NL2021630B1 Polyurethane sheet
NL2021637B1 Breath sampler
NL2021401B1 Heart support device with directional flow assist
NL2021132B1 Storage control system comprising a supercontinuum laser source.
US2020032347A1 RNA profiling for individualized diet and treatment advice.